Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000732143 | SCV000860053 | uncertain significance | not provided | 2018-03-06 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001193611 | SCV001362559 | likely benign | not specified | 2020-01-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001504524 | SCV001709406 | likely benign | Zellweger spectrum disorders | 2024-10-21 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001504524 | SCV002076837 | likely benign | Zellweger spectrum disorders | 2017-10-17 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003965534 | SCV004778209 | likely benign | PEX1-related disorder | 2019-10-25 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |